Company Filing History:
1 out of 54 
1 out of 1,743 
1 out of 21 Years Active: 2024
Title: Evelyne Gicquel: Innovator in Gene Therapy
Introduction
Evelyne Gicquel is a prominent inventor based in Vert-le-Petit, France. She has made significant contributions to the field of gene therapy, particularly through her innovative work on adeno-associated viruses.
Latest Patents
Evelyne Gicquel holds a patent for a hybrid recombinant adeno-associated virus serotype that combines AAV9 and AAVrh74. This invention features a recombinant hybrid AAV capsid protein that exhibits reduced liver tropism compared to its parent serotypes. The hybrid AAV serotype vector particles are designed to package a gene of interest, making them valuable for gene therapy applications, especially in treating neuromuscular genetic diseases.
Career Highlights
Throughout her career, Evelyne has worked with notable organizations such as Genethon and the Institut National de la Santé et de la Recherche Médicale. Her work has been instrumental in advancing the understanding and application of gene therapy techniques.
Collaborations
Evelyne has collaborated with esteemed colleagues, including Isabelle Richard and Federico Mingozzi, contributing to the collective knowledge and innovation in her field.
Conclusion
Evelyne Gicquel's contributions to gene therapy through her innovative patents and collaborations highlight her role as a leading inventor in the medical research community. Her work continues to pave the way for advancements in treating genetic diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.